carvedilol has been researched along with Decerebrate Posturing in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clinical studies conducted with carvedilol suggest that beta-adrenoceptor antagonism is an effective therapeutic approach to the treatment of heart failure." | 3.70 | In vitro and in vivo characterization of intrinsic sympathomimetic activity in normal and heart failure rats. ( Aiyar, N; Disa, J; Mitchell, MP; Naselsky, DP; Ohlstein, EH; Ruffolo, RR; Stadel, JM; Storer, BL; Willette, RN; Yue, TL, 1999) |
| "Carvedilol was recently approved for the treatment of congestive heart failure, and bucindolol is currently in large clinical trials for this indication." | 1.30 | Evaluation of intrinsic sympathomimetic activity of bucindolol and carvedilol in rat heart. ( Lukas, MA; Mitchell, MP; Ohlstein, EH; Ruffolo, RR; Willette, RN, 1998) |
| " Furthermore, in the pithed rat, the alpha 1-adrenoceptor-mediated pressor dose-response curve to cirazoline was shifted approximately 6-fold to the right by both the (+)-R- and (-)-S-enantiomers of carvedilol at a dose of 1 mg/kg, i." | 1.28 | The interaction of the enantiomers of carvedilol with alpha 1- and beta 1-adrenoceptors. ( Ashton, DJ; Hieble, JP; Nichols, AJ; Ruffolo, RR; Sulpizio, AC, 1989) |
| " Labetalol and prazosin also significantly shifted the dose-response curve to the right for phenylephrine but not for angiotensin II." | 1.27 | Analysis of the mechanism underlying the vasodilator action of carvedilol in pithed spontaneously hypertensive rats. ( Akashi, A; Hashimoto, H; Kanda, A; Tanaka, M, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Willette, RN | 2 |
| Mitchell, MP | 2 |
| Ohlstein, EH | 2 |
| Lukas, MA | 1 |
| Ruffolo, RR | 3 |
| Aiyar, N | 1 |
| Yue, TL | 1 |
| Disa, J | 1 |
| Storer, BL | 1 |
| Naselsky, DP | 1 |
| Stadel, JM | 1 |
| Bartsch, W | 1 |
| Sponer, G | 1 |
| Strein, K | 1 |
| Müller-Beckmann, B | 1 |
| Kling, L | 1 |
| Böhm, E | 1 |
| Martin, U | 1 |
| Borbe, HO | 1 |
| Nichols, AJ | 1 |
| Sulpizio, AC | 1 |
| Ashton, DJ | 1 |
| Hieble, JP | 1 |
| Hashimoto, H | 1 |
| Tanaka, M | 1 |
| Kanda, A | 1 |
| Akashi, A | 1 |
5 other studies available for carvedilol and Decerebrate Posturing
| Article | Year |
|---|---|
Evaluation of intrinsic sympathomimetic activity of bucindolol and carvedilol in rat heart.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Decerebrate State; Drug Evaluation, Pr | 1998 |
In vitro and in vivo characterization of intrinsic sympathomimetic activity in normal and heart failure rats.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Bisoprolol; Carbaz | 1999 |
Pharmacological characteristics of the stereoisomers of carvedilol.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Blood Pressure; | 1990 |
The interaction of the enantiomers of carvedilol with alpha 1- and beta 1-adrenoceptors.
Topics: Adrenergic beta-Antagonists; Anesthesia; Animals; Carbazoles; Carvedilol; Decerebrate State; Guinea | 1989 |
Analysis of the mechanism underlying the vasodilator action of carvedilol in pithed spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Carbazoles; Carvedilol; Decerebrate State; Dos | 1988 |